Buchuan Tan1, Long Liu1, Yushuang Yang1, Qian Liu1, Liping Yang2, Fanbo Meng3. 1. Cardiology Department of the China-Japan Union Hospital of Jilin University, Changchun, China. 2. Peking University Shenzhen Hospital, Shenzhen, China. 3. Cardiology Department of the China-Japan Union Hospital of Jilin University, Changchun, China. mengfb@jlu.edu.cn.
Abstract
BACKGROUND: Gene COPINE III may be related to a phosphoprotein with intrinsic kinase activity and belongs to an unconventional kinase family. The CPNE3 gene may be used as a biomarker for assess- ment of occurrence and prognosis of various tumors. METHODS: Peripheral blood was collected from 87 stable coronary artery disease (CAD) patients and 91 acute myocardial infarction (AMI) patients. Real-time quantitative polymerase chain reaction test and the western blot method were adopted to measure expression quantity of CPNE3 gene at the mRNA level and the protein level. RESULTS: The expression of the CPNE3 gene in peripheral blood of AMI patients was significantly lower than those in peripheral blood of stable CAD patients. Low expression of CPNE3 gene was found to be unrelated to level of fasting blood glucose and serum blood lipid of patients, quantity of cardiac troponin and time of onset but was found to be correlated to the Gensini score for coronary artery. When the ex- pression of CPNE3 gene at the mRNA level in peripheral blood was used as the criterion for diagnosing AMI, its sensitivity, specificity, positive predictive value and negative predictive value were 69%, 64.8%, 68.6% and 65.2%, respectively. CONCLUSIONS: Compared to stable CAD patients, AMI patients have a lower expression of CPNE3 gene in their peripheral blood. Patients who have low CPNE3 expression in peripheral blood are more likely to suffer from AMI than those with stable CAD. Low expression of CPNE3 gene serves as an potential independent risk factor of AMI.
BACKGROUND: Gene COPINE III may be related to a phosphoprotein with intrinsic kinase activity and belongs to an unconventional kinase family. The CPNE3 gene may be used as a biomarker for assess- ment of occurrence and prognosis of various tumors. METHODS: Peripheral blood was collected from 87 stable coronary artery disease (CAD) patients and 91 acute myocardial infarction (AMI) patients. Real-time quantitative polymerase chain reaction test and the western blot method were adopted to measure expression quantity of CPNE3 gene at the mRNA level and the protein level. RESULTS: The expression of the CPNE3 gene in peripheral blood of AMI patients was significantly lower than those in peripheral blood of stable CAD patients. Low expression of CPNE3 gene was found to be unrelated to level of fasting blood glucose and serum blood lipid of patients, quantity of cardiac troponin and time of onset but was found to be correlated to the Gensini score for coronary artery. When the ex- pression of CPNE3 gene at the mRNA level in peripheral blood was used as the criterion for diagnosing AMI, its sensitivity, specificity, positive predictive value and negative predictive value were 69%, 64.8%, 68.6% and 65.2%, respectively. CONCLUSIONS: Compared to stable CAD patients, AMI patients have a lower expression of CPNE3 gene in their peripheral blood. Patients who have low CPNE3 expression in peripheral blood are more likely to suffer from AMI than those with stable CAD. Low expression of CPNE3 gene serves as an potential independent risk factor of AMI.
Authors: Gilles Montalescot; Udo Sechtem; Stephan Achenbach; Felicita Andreotti; Chris Arden; Andrzej Budaj; Raffaele Bugiardini; Filippo Crea; Thomas Cuisset; Carlo Di Mario; J Rafael Ferreira; Bernard J Gersh; Anselm K Gitt; Jean-Sebastien Hulot; Nikolaus Marx; Lionel H Opie; Matthias Pfisterer; Eva Prescott; Frank Ruschitzka; Manel Sabaté; Roxy Senior; David Paul Taggart; Ernst E van der Wall; Christiaan J M Vrints; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Juhani Knuuti; Marco Valgimigli; Héctor Bueno; Marc J Claeys; Norbert Donner-Banzhoff; Cetin Erol; Herbert Frank; Christian Funck-Brentano; Oliver Gaemperli; José R Gonzalez-Juanatey; Michalis Hamilos; David Hasdai; Steen Husted; Stefan K James; Kari Kervinen; Philippe Kolh; Steen Dalby Kristensen; Patrizio Lancellotti; Aldo Pietro Maggioni; Massimo F Piepoli; Axel R Pries; Francesco Romeo; Lars Rydén; Maarten L Simoons; Per Anton Sirnes; Ph Gabriel Steg; Adam Timmis; William Wijns; Stephan Windecker; Aylin Yildirir; Jose Luis Zamorano Journal: Eur Heart J Date: 2013-08-30 Impact factor: 29.983
Authors: Terry A Jacobson; Matthew K Ito; Kevin C Maki; Carl E Orringer; Harold E Bays; Peter H Jones; James M McKenney; Scott M Grundy; Edward A Gill; Robert A Wild; Don P Wilson; W Virgil Brown Journal: J Clin Lipidol Date: 2014-07-15 Impact factor: 4.766
Authors: Paul Frey; David D Waters; David A DeMicco; Andrei Breazna; Larry Samuels; Andrew Pipe; Chuan-Chuan Wun; Neal L Benowitz Journal: Am J Cardiol Date: 2010-12-02 Impact factor: 2.778
Authors: Yuka Otaki; Heidi Gransar; Daniel S Berman; Victor Y Cheng; Damini Dey; Fay Y Lin; Stephan Achenbach; Mouaz Al-Mallah; Matthew J Budoff; Filippo Cademartiri; Tracy Q Callister; Hyuk-Jae Chang; Kavitha Chinnaiyan; Benjamin J W Chow; Augustin Delago; Martin Hadamitzky; Joerg Hausleiter; Philipp Kaufmann; Erica Maffei; Gilbert Raff; Leslee J Shaw; Todd C Villines; Allison Dunning; James K Min Journal: Am J Cardiol Date: 2013-02-11 Impact factor: 2.778
Authors: Michael R Elashoff; James A Wingrove; Philip Beineke; Susan E Daniels; Whittemore G Tingley; Steven Rosenberg; Szilard Voros; William E Kraus; Geoffrey S Ginsburg; Robert S Schwartz; Stephen G Ellis; Naheem Tahirkheli; Ron Waksman; John McPherson; Alexandra J Lansky; Eric J Topol Journal: BMC Med Genomics Date: 2011-03-28 Impact factor: 3.063
Authors: Sirui Zhou; Pingxing Xie; Amélie Quoibion; Amirthagowri Ambalavanan; Alexandre Dionne-Laporte; Dan Spiegelman; Cynthia V Bourassa; Lan Xiong; Patrick A Dion; Guy A Rouleau Journal: Proc Natl Acad Sci U S A Date: 2019-07-22 Impact factor: 11.205
Authors: Hechun Lin; Xiao Zhang; Li Liao; Tao Yu; Jing Li; Hongyu Pan; Lei Liu; Hanwei Kong; Lei Sun; Mingxia Yan; Ming Yao Journal: J Cancer Date: 2018-10-20 Impact factor: 4.207
Authors: Timothy A McCaffrey; Ian Toma; Zhaoquing Yang; Richard Katz; Jonathan Reiner; Ramesh Mazhari; Palak Shah; Michael Tackett; Dan Jones; Tisha Jepson; Zachary Falk; Richard Wargodsky; Dmitry Shtakalo; Denis Antonets; Justin Ertle; Ju H Kim; Yinglei Lai; Zeynep Arslan; Emily Aledort; Maha Alfaraidy; Georges St Laurent Journal: BMC Med Genomics Date: 2021-09-03 Impact factor: 3.063